This inventor holds 3 USPTO granted patents and 4 published patent applications, plus 2 CIPO patents and 1 EPO patent. Top assignees: Biomed Canada Corporation, University of Manitoba, Other. Active years: 2018-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 1 
1 out of 213 
1 out of 834,659 Years Active: 2018-2025
Title: Innovations by Francis Lin in Microfluidic Technology
Introduction
Francis Lin is an accomplished inventor based in Winnipeg, Canada. He has made significant contributions to the field of microfluidics, particularly in the diagnosis and monitoring of chronic kidney disease. With a total of three patents to his name, Lin's work exemplifies the intersection of technology and healthcare.
Latest Patents
One of Lin's latest patents is the Passive Mixing Microfluidic Urinary Albumin Chip (UAL-chip) for chronic kidney disease. This innovative chip utilizes a method for mixing unequal amounts of two reagents to produce a detectable reaction. The UAL-chip features a passive and continuous mixing module that requires only an inexpensive dropper for the loading process. It employs a pressure-balancing strategy based on immiscible oil coverage, which enhances the precision in controlling the mixing ratio of sample and dye. The chip has achieved an estimated limit of detection (LOD) of 8.4 μg/ml using albumin standards, which is below the 30 μg albumin per ml urine level indicative of kidney damage.
Another notable patent is the Microfluidic Based Integrated Sample Analysis System. This portable microfluidic system is capable of rapid diagnosis and can analyze genetic, protein, and cell composition of a sample in parallel for specific diseases. The system utilizes a single microfluidic chip integrated into a unique portable platform, providing improved diagnostic accuracy and facilitating frequent monitoring in clinical settings.
Career Highlights
Francis Lin has worked at the University of Manitoba, where he has contributed to various research projects in microfluidics. His innovative approaches have garnered attention in the scientific community, leading to advancements in diagnostic technologies.
Collaborations
Lin has collaborated with notable colleagues such as Jiandong Wu and Gong Zhang. Their combined expertise has furthered the development of microfluidic technologies and their applications in healthcare.
Conclusion
Francis Lin's contributions to microfluidic technology have the potential to revolutionize diagnostic processes in healthcare. His innovative patents reflect a commitment to improving patient outcomes through advanced technology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile